OptimizeRx Corp — Director's Dealing 2019

Mar 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2019-03-29

Reporting Person: HALAS GUS D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-29	Common Stock	A	2084	—	Acquired	48008	Direct

Footnotes

F1: The Issuer issued these shares to the Reporting Person under the Director Compensation Plan.